What is Septerna, Inc.'s EV / sales?

Septerna, Inc. (SEPN) reported EV / sales of 14.3× in Q1 2026.

How has Septerna, Inc.'s EV / sales changed year-over-year?

Septerna, Inc.'s EV / sales decreased by 80.7% year-over-year, from 74× to 14.3×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Septerna, Inc. SEPN EV / sales

EV / sales at other companies

AmgenAMGN

6.6×+0.1×

Stoke Therapeutics, Inc.STOK

55.3×+54.8×

Nurix Therapeutics, Inc.NRIX

22.7×+2.8×

Fortrea Holdings Inc.FTRE

0.7×0.0×

Catalyst PharmaceuticalCPRX

3.8×-0.6×

Arrowhead ResearchARWR

14×+10.9×

Other financials

Income statement

See full

Revenue$26.5M+12,011%

Operating income-$13.3M+48.7%

Net income-$8.6M+59.8%

EPS (diluted)-$0.19+61.2%

Balance sheet

See full

Cash & equivalents$71.6M-65.9%

Total debt$23.1M-7.7%

Total equity$378.5M+195%

Total assets$569.7M+31.3%

Cash flow

See full

Operating cash flow-$25.6M-9.8%

CapEx$832.0K+118%

Free cash flow-$26.5M-11.5%

Valuation

See full

Market cap$1.62B+319%

Profitability

See full

Operating margin-77.1%-38.4pp

Net margin-49.9%-24.9pp

FCF margin467.9%+243pp

Returns & leverage

See full

Return on equity-12.2%—

Debt / equity0.1×—

Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

enterprise value/total revenue=14.3×

Based on the most recent quarter.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Septerna, Inc.'s EV / sales?: Septerna, Inc. (SEPN) reported EV / sales of 14.3× in Q1 2026.
How has Septerna, Inc.'s EV / sales changed year-over-year?: Septerna, Inc.'s EV / sales decreased by 80.7% year-over-year, from 74× to 14.3×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.